Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

Crystal Amber (CRS) is the best performing UK small-cap closed-end fund over the past 12 months and three years, delivering a 35.2 per cent and 75.6 per cent total return, respectively, according to ...

Q4 2024 Management View CEO David Ricks highlighted a 45% revenue growth in Q4, with significant contributions from Mounjaro and Zepbound. He emphasized ongoing expansion in manufacturing to meet ...

The Company’s Investment Strategy is to construct a portfolio of ethically screened global Securities and Derivatives, designed to provide superior risk adjusted returns to Shareholders. This return ...

Abstract: Recently, the bio-inspired spike camera with continuous motion recording capability has attracted tremendous attention due to its ultra high temporal resolution imaging characteristic. Such ...

AU:MEC)). Morphic Ethical Equities Fund Limited has announced a daily update on its ongoing on-market buy-back of ordinary fully paid securities, identified by the ASX code MEC. This update ...